Analysed MIRUM PHARMACEUTICALS INC (MIRM:NASDAQ) News Sources
PhRMA names next CEO; Pierre Fabre takes third swing at Ebvallo approval
30-09-2026
biopharmadive.com
Mirum Pharmaceuticals' Brevlovitug Hits Phase III Endpoint in Hepatitis Delta Study
02-10-2026
marketbeat.com
Mirum Pharmaceuticals to Host Investor Call to Share Topline Results from the Phase 3 EXPAND Study of LIVMARLI® (maralixibat) in Ultra-Rare Cholestatic Liver Diseases
11-10-2026
yahoo.com
Mirum Pharmaceuticals Announces Primary Endpoint Met in Phase 3 EXPAND Study of LIVMARLI® (maralixibat) in Ultra-Rare Cholestatic Liver Diseases
12-10-2026
yahoo.com
Mirum Pharmaceuticals' LIVMARLI Study Hits Key Endpoints in Rare Liver Diseases
12-10-2026
marketbeat.com
Mirum tees up Livmarli label expansion on Phase III liver disease study success
12-10-2026
clinicaltrialsarena.com
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
15-10-2026
yahoo.com
What is the current price of MIRUM PHARMACEUTICALS INC (MIRM:NASDAQ)?
The current price of MIRUM PHARMACEUTICALS INC (MIRM:NASDAQ) is $83.94.
MIRUM PHARMACEUTICALS INC (MIRM:NASDAQ) absolute price change since previous trading day?
The absolute price change of MIRUM PHARMACEUTICALS INC (MIRM:NASDAQ) since the previous trading day is $0.67.
MIRUM PHARMACEUTICALS INC (MIRM:NASDAQ) percentage price change since previous trading day?
The percentage price change of MIRUM PHARMACEUTICALS INC (MIRM:NASDAQ) since the previous trading day is 0.8046%.
What is the most recent average sentiment score for MIRUM PHARMACEUTICALS INC (MIRM:NASDAQ)?
The most recent average sentiment score for MIRUM PHARMACEUTICALS INC (MIRM:NASDAQ) is 89 out of 100.
What is the most recent average sentiment for MIRUM PHARMACEUTICALS INC (MIRM:NASDAQ)?
The most recent sentiment for MIRUM PHARMACEUTICALS INC (MIRM:NASDAQ) is .
SEC-8K** Filing Available For MIRUM PHARMACEUTICALS INC (MIRM:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.